Nathan Sandbo is a Respiratory physician affiliated with University of Wisconsin–Madison. OpenAlex indexes 142 publications with 3,261 citations (h-index 28).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
600 Highland Ave
Madison, WI 537920001
Telephone
608-263-7203Provider last certified this registry record 5 Jan 2021.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
34.1%Proton pump inhibitor17%Pantoprazole Sodium100%Part D<11 patientsCorticosteroid17%Prednisone100%Part D<11 patientsCancer & immunology
34.1%Kinase inhibitor22.2%Ofev100%Part D<11 patientsPyridone11.9%Pirfenidone100%Part D<11 patientsAnti-infectives
31.9%Macrolide Antimicrobial20.7%Azithromycin100%Part D<11 patientsShort-acting sulfonamides11.1%Sulfamethoxazole-Trimethoprim100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
4 NIH research awards on record, funded 2012–2023 per NIH RePORTER. The latest:
- Elucidating tensin1-associated signals that promote fibronectin matrix assembly and lung fibrosis
University of Wisconsin-Madison
FY2023$344,250R01HL146402 - Elucidating tensin1-associated signals that promote fibronectin matrix assembly and lung fibrosis
University of Wisconsin-Madison
FY2022$344,250R01HL146402 - Elucidating tensin1-associated signals that promote fibronectin matrix assembly and lung fibrosis
University of Wisconsin-Madison
FY2021$344,250R01HL146402
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- [68 Ga]Ga-FAPI-46 PET for non-invasive detection of pulmonary fibrosis disease activity
European Journal of Nuclear Medicine and Molecular Imaging
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Mark Albertini, MD
University of Wisconsin–Madison
Bryn Webb, MD
University of Wisconsin–Madison
Jeannina Smith, MD
University of Wisconsin–Madison
Carolina Pusec, PhD, MD
University of Wisconsin–Madison
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”